2017
DOI: 10.1016/j.yexcr.2017.08.014
|View full text |Cite
|
Sign up to set email alerts
|

Improved therapeutic efficacy of mammalian expressed-recombinant interferon gamma against ovarian cancer cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
8
0
2

Year Published

2018
2018
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(11 citation statements)
references
References 40 publications
1
8
0
2
Order By: Relevance
“…The different eukaryotic expression systems producing specific N-glycan would also affect therapeutic applications. For example, mammalian-expressed hIFNγ with complex-type glycosylation exhibited higher levels of biological activity against cancer cells compared to its deglycosylated form (Razaghi et al, 2017b). However, the heterogeneous N-glycan side chains of plantproduced hIFNγ have not yet been completely identified to date.…”
Section: Post-translational Modification During Protein Transportatiomentioning
confidence: 99%
“…The different eukaryotic expression systems producing specific N-glycan would also affect therapeutic applications. For example, mammalian-expressed hIFNγ with complex-type glycosylation exhibited higher levels of biological activity against cancer cells compared to its deglycosylated form (Razaghi et al, 2017b). However, the heterogeneous N-glycan side chains of plantproduced hIFNγ have not yet been completely identified to date.…”
Section: Post-translational Modification During Protein Transportatiomentioning
confidence: 99%
“…In the study by Liu S. et al 51 it was observed that specific expression of interferon-γ induced by synergistic activation mediator-derived (SAM) systems activates innate immunity and inhibits tumorigenesis. In the study by Razaghi A. et al 52 improved therapeutic efficacy of mammalian expressed-recombinant interferon gamma against ovarian cancer cells was observed. In the study by Li Z. et al 53 it was observed that anti-VEGFR-interferon-α2 regulates the tumor microenvironment and exhibits potent antitumor efficacy against colorectal cancer.…”
Section: Interferon-γmentioning
confidence: 99%
“…The main objective of this research was to cluster the patients using their data expression of 20 genes which, based on the clinical literature, are the most effective genes in prediction, diagnosis and treatment of the ovarian cancer (Windbichler et al, 2000;Sers et al, 2002;Marth et al, 2004;Manrique et al, 2011;Bankaitis and Fingleton, 2015;Berinstein et al, 2015;Shang et al, 2015;Comisso et al, 2017;Razaghi et al, 2017;Yokoyama et al, 2017). Since one cannot exactly determine which method is always the most appropriate clustering method for a data type (Ciaramella and Staiano, 2019), comparison of different methods on a data set is of great importance.…”
Section: Evaluation Of Twenty Genes In Prognosis Of Patients With Ovarian Cancer Using Four Different Clustering Methodsmentioning
confidence: 99%